N 6 -2-hydroxyethyl-adenosine ameliorate cisplatin induced acute kidney injury in mice
Rattachement africain : hk, cn, th. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
N6-2-hydroxyethyl-adenosine (HEA) is one of the main bioactive components found in Cordyceps cicadae and it has been reported to display antioxidant and anti-inflammatory activities. Cisplatin (CP) is one of the most commonly used chemotherapeutic drug for treating various cancers and tumors, but the use is widely curtailed due to its toxicity of various organs including the kidney. This study was aimed at investigating the protective effect of HEA on cisplatin-induced kidney injury. Mice were pretreated with HEA for 7 days and administered with cisplatin. Kidney function index including blood urea nitrogen (BUN), creatinine, renal oxidative stress and pro-inflammatory indices such as malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), tumor necrosis factor (TNF-α), interleukin 1 beta (IL-1β) and interleukin 6 (IL-6) were measured. Histopathological assessment of the kidney was also performed. The results indicated that HEA noticeably modulated the levels of BUN and creatinine as well as decreased the expression of MDA, TNF-α, IL-1β and IL-6 in the kidney. In addition, HEA up regulated the activities of antioxidant enzymes SOD, CAT and GSH-Px. Therefore, we concluded that HEA could effectively alleviate cisplatin-induced nephrotoxicity by counteracting oxidative stress and inflammation.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- N <sup>6</sup> -2-hydroxyethyl-adenosine ameliorate cisplatin induced acute kidney injury in mice
- Date Crossref
- 01/01/2020
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Union Hospital Department of Nephrology pays non établi dans la noticeÉtablissement de santé
-
Jilin University pays non établi dans la noticeUniversité ou école supérieure
-
Prince of Songkla University pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of Thai Traditional Medicine pays non établi dans la noticeUniversité ou école supérieure
Department of Nephrology — Union Hospital, Jilin University et Prince of Songkla University, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.